Your browser doesn't support javascript.
loading
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Lee, Chung-Han; Yogesh Shah, Amishi; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Gironés Sarrió, Regina; Lee Cohn, Allen; Asim Bilen, Mehmet; Gunnestad Ribe, Sara; Krohn Tennøe, Øyvind; Richards, Donald; Sweis, Randy F; Courtright, Jay; Heinrich, Daniel; Perini, Rodolfo; Kubiak, Peter; Bock, Daena; Okpara, Chinyere E; Motzer, Robert J.
Afiliación
  • Lee CH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Yogesh Shah A; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Rao A; Division of Hematology and Oncology, East Park Medical Group, Houston, TX, USA.
  • Taylor MH; Division of Hematology and Oncology, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.
  • Di Simone C; Medical Oncology/Hematology, Arizona Oncology Associates, Tucson, AZ, USA.
  • Hsieh JJ; Department of Medicine, Oncology Division, Washington University School of Medicine, St. Louis, MO, USA.
  • Pinto A; Servicio de Oncología, Hospital Universitario La Paz, Madrid, Spain.
  • Gironés Sarrió R; Medical Oncology Service, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Lee Cohn A; Medical Oncology, US Oncology Research, Rocky Mountain Cancer Center, Denver, CO, USA.
  • Asim Bilen M; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Gunnestad Ribe S; Medical Oncology, Sorlandet Hospital Kristiansand, Kristiansand, Norway.
  • Krohn Tennøe Ø; Sykehuset Østfold, Sarpsborg, Norway.
  • Richards D; Department of Oncology, US Oncology Research, Texas Oncology-Tyler, Tyler, TX, USA.
  • Sweis RF; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Courtright J; Department of Oncology, US Oncology Research, Texas Oncology, Dallas, TX, USA.
  • Heinrich D; Department of Oncology and Radiotherapy, Innlandet Hospital Trust, Gjøvik, Norway.
  • Perini R; Clinical Research, Merck & Co. Inc, Rahway, NJ, USA.
  • Kubiak P; Clinical Research, Eisai Inc, Nutley, NJ, USA.
  • Bock D; Biostatistics, Eisai Inc, Nutley, NJ, USA.
  • Okpara CE; Clinical Research, Eisai Ltd, Hatfield, UK.
  • Motzer RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: motzerr@mskcc.org.
Eur Urol ; 2024 May 21.
Article en En | MEDLINE | ID: mdl-38777648
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur Urol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Eur Urol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos